Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
about
Clinical impacts of mesothelin expression in gastrointestinal carcinomasPrognostic value of several biomarkers for the patients with malignant pleural mesothelioma.Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis.A new anti-mesothelin antibody targets selectively the membrane-associated form.
P2860
Serum soluble mesothelin-related peptide (SMRP): a potential diagnostic and monitoring marker for epithelial ovarian cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Serum soluble mesothelin-relat ...... for epithelial ovarian cancer.
@en
Serum soluble mesothelin-related peptide
@nl
type
label
Serum soluble mesothelin-relat ...... for epithelial ovarian cancer.
@en
Serum soluble mesothelin-related peptide
@nl
prefLabel
Serum soluble mesothelin-relat ...... for epithelial ovarian cancer.
@en
Serum soluble mesothelin-related peptide
@nl
P2093
P2860
P1476
Serum soluble mesothelin-relat ...... for epithelial ovarian cancer.
@en
P2093
Dongxiu Li
Hongxia Liang
Liping Liu
Xiaohua Wu
P2860
P2888
P304
P356
10.1007/S00404-013-3128-X
P577
2013-12-27T00:00:00Z